Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. It specializes in the field of CpG oligonucleotides. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.
Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY.
(US) ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.
China Index Holdings Ltd. is an investment holding company. It operates a real estate information and analytics service platform. Its services span across data, analytics, promotion and listing services. The company was founded by Tianquan Mo on August 10, 2007 and is headquartered in Fengtai District, China.
(China (Mainland)) Chindata Group Holdings Ltd. operates data centers. It provides carrier-neutral hyperscale data center solutions in Asia-Pacific emerging markets, focusing on the China, India and Southeast Asia markets. The company was founded by Jing Ju in 2015 and is headquartered in Beijing, China.
(US) Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.
Cincinnati Bancorp, Inc. operates as a bank holding company. It engages in the business of personal banking, lending and business banking. It involves in taking deposits from the general public and investing those deposits in family residential real estate, non residential real estate, multi-family, home equity, construction and land loans. The company was founded in 1922 and is headquartered in Cincinnati, OH.
Citizens Holding Co. operates as a bank holding company, which provides commercial and personal banking services through the Citizens Bank of Philadelphia. Its activities include the accepting demand deposits, savings and time deposit accounts, making secured and unsecured loans, issuing letters of credit, originating mortgage loans, and providing personal and corporate trust services. The company was founded on February 16, 1982 and is headquartered in Philadelphia, MS.
Citrix Systems, Inc. engages in the design, development, and marketing of information technology solutions. It provides digital workspace that unifies apps, data, and services. It markets and licenses its products directly to customers through web, systems integrators, value-added resellers, and service providers. The company was founded by Edward E. Iacobucci on April 17, 1989 and is headquartered in Fort Lauderdale, FL.
Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of cancer treatments. Its marketed product Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is offered for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer; and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO.
CMC Materials, Inc. engages in the development, manufacture, and sale of chemical mechanical planarization consumables products. It operates through the following segments: Electronic Materials and Performance Material. The Electronic Materials segment consists of CMP slurries and polishing pads businesses and KMG electronic chemicals business. The Performance Materials segment includes KMG's heritage pipeline performance and wood treatment businesses and QED business. The firm offers chemical mechanical planarization slurries for polishing many of the conducting, insulating and isolating materials used in integrated circuit devices, and for polishing the disk substrates and magnetic heads used in hard disk drives. It also develops, manufactures and sells chemical mechanical planarization polishing pads, which are used in conjunction with slurries in the chemical mechanical planarization process. The company was founded by William P. Noglows in October 1999 and is headquartered in Aurora, IL.
(United States) Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. The company was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA.
(US) AgroFresh Solutions, Inc. engages in the provision of food preservation and waste reduction solutions for fresh produce. It offers products through the following brands: Smarter Freshness, Harvista, LandSpring, SmartFresh, AdvanStore, and ActiMist, Textar, and Teycer. The company was founded on October 24, 2013 and is headquartered in Philadelphia, PA.
Akouos, Inc. engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA.
Akumin, Inc. engages in the provision of outpatient diagnostic imaging services. Its services include magnetic resonance imaging, computerized tomography, positron emission tomography, ultrasound, X-ray, mammography and other diagnostic or interventional radiology procedures. The company was founded on August 12, 2015 and is headquartered in Toronto, Canada.
(US) Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. It pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.
Alithya Group, Inc. engages in the provision of information technology consulting services. Its caters financial services, manufacturing, energy, telecommunications, transportation and logistics, professional services, healthcare, and government sectors. It operates through the following geographical segments: Canada, USA, and Europe. The firm's services and solutions include oracle solutions, Microsoft solutions, digital solutions center, energy services, digital strategy and transformation, project management, and infrastructure management. The company was founded by Ghyslain Rivard in 1992 and is headquartered in Montreal, Canada.
Allegiance Bancshares, Inc. operates as a bank holding company. It engages in the provision of commercial banking services primarily to Houston metropolitan area-based small to medium-sized businesses and individual customers. The company was founded by George Martinez and Steven F. Retzloff in 2007 and is headquartered in Houston, TX.
(United States) Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company, which engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults; and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease. The company was founded by Robert Gallotto and Alexey L. Margolin on June 24, 2011 and is headquartered in Newton, MA.
Allied Healthcare Products, Inc. manufactures, markets, and distributes a variety of respiratory products used in the health care industry to hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, and emergency medical product dealers. Its products include respiratory care products, medical gas equipment, and emergency medical products. The company was founded in 1979 and is headquartered in St. Louis, MO.